Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2026-04-08

FDA Approved: LEVETIRACETAM SOLUTION — Supplemental Application (Chartwell RX, LLC)

View source ↗

Summary

FDA approved a supplemental application for LEVETIRACETAM SOLUTION from Chartwell RX, LLC, granting approval under the ANDA process.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LEVETIRACETAM SOLUTION (LEVETIRACETAM)

Snippet

SUPPL AP for LEVETIRACETAM SOLUTION (LEVETIRACETAM)